The Concept of CMR
Slides, videos and more
Editorials from the Chair
November 12, 2013 Eat well, drink well, move… A small step for you, a big step for Europe
News
-
December 06, 2013 Very high fructose intake increases serum LDL-cholesterol and total cholesterol: a meta-analysis of controlled feeding trials. J Nutr 2013;143:1391-8
Zhang YH, An T, Zhang RC, Zhou Q, Huang Y, Zhang J.
-
December 06, 2013 Concurrent physical activity modifies the association between n3 long-chain fatty acids and cardiometabolic risk in midlife adults. J Nutr 2013;143:1414-20
Muldoon MF, Erickson KI, Goodpaster BH, Jakicic JM, Conklin SM, Sekikawa A, Yao JK, Manuck SB.
-
December 06, 2013 Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes. J Nutr 2013;143:1474-80
Jacques PF, Cassidy A, Rogers G, Peterson JJ, Meigs JB, Dwyer JT.
-
December 05, 2013 Presentation, management, and outcomes of ischaemic heart disease in women. Nat Rev Cardiol 2013;10:508-18
Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Manfrini O, Koller A, Pries A, Cenko E, Bugiardini R.
Subscribe to our Newsletter
Keep up with all the latest from the cardiometabolic world. For breaking news, website updates and exclusive invitations to events with your peers.
CMR Fun Clips
Watch Dr. Cheese and the Potato family’s funny videos and learn simple notions about abdominal obesity and related health.
Calendar of Events
-
December 2 to 6, 2013
Melbourne, Australia World Diabetes Congress -
December 12 to 14, 2013
Paris, France 1st ICAN Conference Series on Cardiometabolic Diseases
Recent Contributions
-
Expert Opinions How do you see adipose tissue as a target for the management of cardiometabolic risk?
Michael Jensen, MD, Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA
-
Expert Opinions Could you elaborate on the multiple target therapies to manage high-risk patients with abdominal obesity and the metabolic syndrome?
Kwang Kong Koh, MD, PhD, FACC, FAHA, Professor, Vascular Medicine and Atherosclerosis Unit Cardiology, Gachon University Gil Medical Center, Incheon, South Korea
-
Expert Opinions As an academic cardiologist, do you believe that abdominal obesity may eventually become a useful target of CVD risk reduction?
Peter Libby, MD, Chief, Cardiovascular Medicine, Brigham and Women's Hospital, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, USA
In the Spotlight
-
Expert Opinions What are the key predictors of the risk of developing type 2 diabetes?
Beverley Balkau, PhD, INSERM, Center for Research in Epidemiology and Population Health, Epidemiology of Diabetes, Obesity, and Chronic Kidney Disease over the Lifecourse, University Paris Sud, Unité mixte de recherche en santé, Villejuif, France
-
Slide Library Lifestyle modification in the prevention of type 2 diabetes: The experience with the Diabetes Prevention Program and Look AHEAD studies
The International Chair on Cardiometabolic Risk
-
Webcasts The atherogenic dyslipidemia of abdominal obesity
The International Chair on Cardiometabolic Risk
